Alcon, Inc. ALC delivered fourth-quarter 2024 core earnings per share (EPS) of 72 cents, up 2.9% from the year-ago quarter’s figure (up 3% at constant exchange rate or CER). The figure topped the ...

Deerfield Management claims that Alcon Research is seeking a discounted takeover of Aurion Biotech while blocking the startup’s efforts to go public.

Alcon forecast sales of between $10.2 and $10.4 billion for 2025, after the eye care group reported higher fourth-quarter revenue underpinned by its surgical division on Tuesday.

TORONTO, February 27, 2025--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the availability of expanded parameters for TOTAL30 ...

Novartis’ long-awaited separation from its eye care division Alcon completed on schedule today, allowing it to focus its energies on medicinal products. Alcon’s shares made their debut on the ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

RBC Capital analyst Jack Reynolds-Clark reiterated a Buy rating on Alcon (ALC – Research Report) yesterday and set a price target of ...

Alcon announced the US launch of SYSTANE PRO Preservative-Free (PF) as part of the company’s dry eye products. The ...

Reports Q4 revenue $2.48B, consensus $2.47B. “In 2024, our unwavering focus on innovation and operational excellence delivered another set of ...

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments ...